elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47718879-385C0B74-53CD-4795-978E-8A0D45ACF375
Q47718879-385C0B74-53CD-4795-978E-8A0D45ACF375
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47718879-385C0B74-53CD-4795-978E-8A0D45ACF375
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
P6179
Q47718879-385C0B74-53CD-4795-978E-8A0D45ACF375
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47718879-385C0B74-53CD-4795-978E-8A0D45ACF375
rank
NormalRank
type
BestRank
Statement
P6179
1100559771
http://www.w3.org/2001/XMLSchema#string